Bayer stock at EUR 43.60 ahead of the Xetra open: health and crop group little changed
Published on 10/21/2026 at 07:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReporting calendar and company scope
- Bayer operates across three business areas: Crop Science, Pharmaceuticals and Consumer Health.
- Bayer's investor-relations materials list third-quarter 2026 results among its reporting items.
- Bayer stock trades pre-market at EUR 43.60 at 7:49 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.28 percent above the Xetra close of October 20, 2026.
Bayer develops medicines, crop-science products and consumer-health goods, according to its Investor Relations site. Bayer stock trades pre-market at EUR 43.60 at 7:49 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.28 percent above the Xetra close of October 20, 2026 (EUR 43.48).
Ahead of the Xetra open
The pre-market indication is EUR 0.12 above the Xetra close. The bid is EUR 43.51 and the ask is EUR 43.68. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Bayer stock.
The group and its reporting
Bayer earns revenue through businesses in Crop Science, Pharmaceuticals and Consumer Health, as described by its Investor Relations site. The page lists quarterly communications for the first and third quarters and half-year financial reports, including Q3 2026 results. Market context: Market report DAX.
